Human umbilical cord blood: Immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells

Haematologica

Volumn 81, Issue 5, 1996, Pages 404-409

  D'Arena, Giovanni ^a   Musto, Pellegrino ^a   Cascavilla, Nicola ^a   Di Giorgio, Girolamo ^a   Zendoli, Federica ^a   Carotenuto, Mario ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

CD34; Flow cytometry; Hemopoietic progenitor cells; Human umbilical cord blood

Indexed keywords

CD34 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CYTAPHERESIS; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOID CELL; STEM CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BLOOD CELL COUNT; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; PREGNANCY;

EID: 0030322242     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Civin CI, Strauss LC, Brovall M, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic cell surface antigen defined by a monoclonal antibody raised against KG-Ia cells. J Immunol 1984; 133:157-61.
2. Greaves MF, Brown J, Holgaard HV, et al. Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia 1992; 6(suppl 1):31-6.
3. Sutherland DR, Keating A. The CD34 antigen: structure, biology, and potential clinical applications. J Hematother 1992;1:115-29.
4. Carlo-Stella C, Cazzola M, De Fabritiis P, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995; 80:367-87.
5. Almici C, Carlo-Stella C, Wagner JE, Rizzoli V. Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 1995; 80:473-9.
6. Krause DS, Fackler MJ, Civin CI, Stratford M. CD34: structure, biology, and clinical utility. Blood 1996; 87:11-3.
7. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74:1905-14.
8. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2:580-5.
9. Siena S, Bregni M, Brando M, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitor for autologous transplantation in cancer patients. Blood 1991; 77:400-9.
10. D'Arena G, Scalzulli P, Musto P. Circulating hematopoietic progenitor cells in leukapheresis: flow cytometric estimation (Letter). Haematologica 1996; 81:95-6.
11. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Nad Acad Sci USA 1989; 86:3828-32.
12. Broxmeyer HE, Gluckman E, Auerbach A, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Clon 1990; 8:76-91.
13. Wagner JE, Kernan NA, Broxmeyer HE, Gluckman E. Transplantation of umbilical cord blood in 50 patients: analysis of the registry data (Abstr). Blood 1994; 84 (suppl 1): 395.
14. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346:214-9.
15. Bender JG, Unverzagt KL, Walker DE, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77:2591-6.
16. Saeland S, Duvert V, Caux C, et al. Distribution of surface membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp Hematol 1992; 20:24-33.
17. Steen R, Tjonnfjord GE, Egeland T. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother 1994; 3:253-62.
18. Fritsch G, Stimpel M, Kurz M, et al. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 1996; 17:169-78.
19. D'Arena G, Cascavilla N, Musto P, et al. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. Haematologica 1996; 81:215-23.
20. + cells in bone marrow by flow cytometry. J Hematother 1993; 2:305-13.
21. - progenitor cells. Blood 1991; 77:1218-27.
22. Huang S, Terstappen LWMM. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. (Letter) Nature 1992; 360: 745-9.
23. - hematopoietic stem cells. Blood 1994; 83:1515-26.
24. + bone marrow cells. Blood 1994; 84:147-81.
25. Berardi AC, Wang A, Levine JD, Lopez P, Scadden D. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267:104-8.
26. - cells in cord blood and bone marrow. Blood 1995; 86:3745-53.
27. Traycoff CM, Abboud MR, Laver J, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994; 22:215-22.
28. Traycoff CM, Abboud MR, Laver J, et al. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Blood Cells 1994; 20:382-91.
29. Payne TA, Traycoff CM, Laver J, Xu F, Srour EF, Abboud MR. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Bone Marrow Transplant 1995; 15:187-92.
30. Lu L, Shen RN, Broxmeyer HE. Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Grit Rev Oncol Hematol 1996; 22:61-78.
31. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12:28-36.
32. Gordon MY, Blackett NM. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transpl 1995; 15:659-62.
33. Bernstein SH, Barnett M, Cairo M, et al. A multicenter observational study of platelet utilization among recipients of myeloablative therapy and stem cell transplantation (Abstract). Proceedings of the Thirty-Second Annual Meeting of American Society of Clinical Oncology, Philadelphia, May 10-21, 1996; p. 84.
34. Gianni AM. Where do we stand with respect to the use of peripheral blood progenitor cells? Ann Oncol 1994; 5:781-4.
35. Siena S, Bregni M, Di Nicola M, et al. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 1994; 5:935-41.
36. Jenney MEM. Umbilical cord blood transplantation: is there a future? (Letter). Lancet 1995; 346:921-2.
37. Neudorf SML, Blatt J, Corey S, et al. Graft failure after an umbilical cord blood transplant in a patient with severe aplastic anemia. (Letter). Blood 1995; 85:2991-2.
38. Henschler R, Brugger W, Luft T, Frey T, Mertelsmann R, Kanz L. Maintenance of transplantation potential in ex vivo expanded CD34+ selected human peripheral blood progenitor cells. Blood 1994; 84:2898-903.
39. Urashima M, Hoshi Y, Akiyama M, et al. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines. Acta Paediatr JPN 1995; 37:160-5.
40. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082-8.